[Skip to Navigation]
Sign In
Comment & Response
January 24, 2019

Methodology Flaws and Implications of a Complementary Medicine Study

Author Affiliations
  • 1Oslo, Norway
  • 2School of Economics and Business, Norwegian University of Life Sciences, Ås, Norway
  • 3Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
JAMA Oncol. 2019;5(3):431-432. doi:10.1001/jamaoncol.2018.6628

To the Editor In a retrospective case-control study using records from the US National Cancer Database with 1:4 matching of 258 vs 1032 patients with cancer, Johnson et al1 reported: (1) reduced survival among the 258 patients who used at least 1 conventional treatment together with complementary medicine (CM) compared with the 1032 patients who used only conventional treatment and (2) an association between the use of CM and refusal of standard treatment. The authors concluded that such refusal may explain the reduced survival. Herein, we briefly argue why we are not convinced that the authors’ results support their conclusion.

Add or change institution